AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vogtis GM 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Atlantis Formulations Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Vogtis GM 2mg/500mg/0.3mg Tablet

Diabex Trio 2mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabex Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your glycemic control. Continued use is crucial, even with well-managed blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as advised by your doctor. Lifestyle modifications are integral to effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, trembling) and appropriate countermeasures. Maintain regular mealtimes and carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Vogtis GM 2mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Vogtis GM 2mg/500mg/0.3mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Vogtis GM 2mg/500mg/0.3mg tablets should be consumed on an empty stomach.

Common Side effects of Vogtis GM 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Vogtis GM 2mg/500mg/0.3mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vogtis GM 2mg/500mg/0.3mg tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.

How Vogtis GM 2mg/500mg/0.3mg Tablet works:

Each Vogtis GM tablet (2mg/500mg/0.3mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vogtis GM 2mg/500mg/0.3mg Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vogtis GM 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vogtis GM 2mg/500mg/0.3mg Tablet while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyUNSAFE

Employing Vogtis GM 2mg/500mg/0.3mg tablets is likely inadvisable for individuals with impaired renal function and should be omitted. Medical guidance is recommended. Furthermore, its use is discouraged in patients experiencing severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Vogtis GM 2mg/500mg/0.3mg Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should involve a reduced dose; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Vogtis GM 2mg/500mg/0.3mg Tablet :

Should you forget a Vogtis GM 2mg/500mg/0.3mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vogtis GM 2mg/500mg/0.3mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Vogtis GM 2mg/500mg/0.3mg Tablet

Vogtis GM 2mg/500mg/0.3mg tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults, enhancing glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion to reduce blood glucose. Metformin decreases hepatic glucose production and increases insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar elevation. This formulation is unsuitable for type 1 diabetes.
Patients taking Vogtis GM 2mg/500mg/0.3mg tablets may experience typical adverse reactions including low blood glucose, nausea, diarrhea, taste disturbances, gas, abdominal discomfort, headache, skin eruptions, and respiratory illness.
Patients with hypersensitivity to any Vogtis GM 2mg/500mg/0.3mg Tablet constituent or inactive ingredient should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and pre-existing metabolic acidosis, including diabetic ketoacidosis.
Combining Vogtis GM 2mg/500mg/0.3mg Tablet with alcohol is unsafe. This combination can reduce blood sugar, potentially causing hypoglycemia, and raise the risk of lactic acidosis.
Indeed, Vogtis GM 2mg/500mg/0.3mg Tablets may induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Vogtis GM 2mg/500mg/0.3mg...
66
MRP 80
17% off